After cake attack on Mona Lisa: Castello CUBE has to be hidden in a safe in the Swiss Alps!
It is the most expensive cube ever made, funded by the booming cryptocurrency Castello Coin. For now, the world-famous Castello CUBE will no longer be open to the public – to protect it from damage and theft.
Zug, Switzerland.
The Castello CUBE attracted worldwide attention when the golden cube by artist Niclas Castello was shown first in New York's Central Park and at the Venice Biennale this year. The work of art, unique in the world, was made of 24 carats, 999.9 fine gold in the oldest art foundry in Europe and weighs 410 lbs. The material value alone is $11.7 Million US-Dollars. Coin and CUBE each act as a bridge between the classic financial world, the world of traditional forms of investment and traditional art and the new world – the world of cryptocurrencies and the digital age.
Initially, the Cube was supposed to be shown in other locations in the US, Europe, Asia and the United Arab Emirates and inspire people worldwide. But security experts advise against it after a risk analysis. The reason: Safety cannot be guaranteed. An activist recently daubed a cake on the Mona Lisa in the Louvre in Paris, luckily protected by a pane. However, the Castello CUBE does not come with such a protective pane.
A spokeswoman of Swiss HoGA Capital AG, which is behind Castello CUBE and Castello Coin, says: "It breaks the artist's and our hearts, but we can no longer show the Cube publicly. The work of art lives from the fact that it stands directly and unprotected outside and becomes one with the earth. However, the risk of the Castello CUBE being intentionally damaged or kidnapped is now too big. With its increased popularity, we can no longer provide security and insurance." The Castello CUBE is now hidden in a secret and heavily guarded depot in the Swiss Alps. Only a handful of people know where.
The popular cryptocurrency Castello Coin, which made the creation of the Castello CUBE possible in the first place, is also freely available - never before has a cryptocurrency created such artistic and material value. After listings on Bittrex and BitMart, the LBank is now the third renowned exchange to trade the Castello Coin - as the leading exchange for digital financial investments.
The HoGA spokeswoman adds: "Only through reliability and trust will people's interest in cryptocurrencies continue to rise. In the challenging cryptocurrency market, our obligation is to give interested buyers various user-friendly and highly secure opportunities to trade the Castello Coin. We attach great importance to listings on the leading stock exchanges worldwide."
The Castello Coin is based on the Ethereum blockchain, which has been active since 2015 and is one of the most secure decentralized transaction databases in the world. The Castello Coin is supported by an international team of consultants from the areas of blockchain and finance: This also includes a close partnership with a Swiss bank. The coin was developed by DSENT AG, which offers the highest level of security, transparency and regulation.
Please send your request to:
More information can be found here:
CAST at LBank:
https://www.lbank.info/exchange/cast/usdt
Twitter:https://twitter.com/castellocoin
Telegram:https://t.me/castellochat
Website: https://castellocoin.com
Blockchain browser:
https://cn.etherscan.com/token/0x3FAb0bBAa03BCEAF7C49E2b12877dB0142BE65FC
Picture is available at AP Images (http://www.apimages.com)
Images
About news aktuell GmbH
As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on www.presseportal.de, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Grünenthal to license osteoarthritis pain treatment to Shionogi in Japan in deal of up to > $ 500 million4.8.2022 09:00:00 CEST | Pressemelding
(Aachen, Germany) Grünenthal and Shionogi announced today that they have entered into a licensing agreement for Grünenthal’s investigational medicine Resiniferatoxin (“RTX”). Shionogi obtained the exclusive rights to commercialise Grünenthal’s asset in Japan for pain associated with osteoarthritis of the knee. RTX is currently in Phase III of clinical development for the treatment of patients with moderate to severe pain associated with knee osteoarthritis. Osteoarthritis, a progressive and often painful joint disease, is an indication with high unmet medical need. If approved, RTX could become a well-tolerated, non-opioid therapy option for patients, providing long-lasting pain relief and functional improvement of the affected knee joints. Under the terms of the agreement, Shionogi will obtain the exclusive commercialisation rights for RTX in Japan for a total consideration of up to $ 525 million plus additional sales based payments. Thereof, Shionogi will pay $ 75 million upon signat
COUNTRY QUEEN IS THE FIRST KENYAN LICENSED BRANDED SERIES ON NETFLIX2.8.2022 15:15:20 CEST | Pressemelding
Country Queen, which premiered in 190 countries exclusively on Netflix 15th of July, is the first high-quality drama series from East Africa to reach a global audience! Launching as No. 1 TV Show in Kenya on Netflix for two weeks in a row, the series continues to gain stellar reviews, more traction and global recognition.
Make some noise for endangered species: Krombacher and Wacken Open Air present the "Growling Creatures" – the first metal band consisting of endangered animals1.8.2022 11:14:47 CEST | Pressemelding
(Krombach, Germany): What do grey seals, cuckoos, and lynx have in common? They are all rare, European native species whose survival is threatened, and they are part of the "Growling Creatures" - the first metal band consisting of endangered animals. Presented by Krombacher and the legendary metal festival Wacken Open Air (W:O:A), this summer the Growling Creatures are drawing attention to their threat and are making some noise for endangered species. "With Krombacher, we have long been committed to domestic and international species protection projects," says Peter Lemm, Head of Communications of the Krombacher brewery. "As a new partner of the Wacken Open Air, it was important for us to create an authentic connection between our sustainable commitment and entertainment with a twinkle in the eye. The Growling Creatures represent exactly this - as musical newcomers of the year, they deliver the best metal sound for the good cause." Animalistic Metal Sound On their mini-EP “Growling Cre
Avsender: R-Biopharm starts commercialization of the fully automated RIDA®UNITY system for real-time PCR in molecular diagnostic laboratories19.7.2022 08:36:55 CEST | Press release
(Darmstadt, Germany): As a fully integrated solution, the new and completely automated RIDA®UNITY system combines sample extraction, PCR setup, real-time PCR and result evaluation in a common workflow. The biotechnology company R-Biopharm AG announced today that it has received the CE mark and will begin selling the new, fully automated RIDA®UNITY system for molecular detection of infectious diseases throughout Europe. "With the RIDA®UNITY system, R-Biopharm is purposefully taking the path from a provider of individual solutions to a system provider in the field of molecular diagnostics," stated Christian Dreher, CEO of R-Biopharm. "We are very happy to make this system solution available to all molecular biology laboratories throughout Europe." Unique combination of different tools The RIDA®UNITY system combines the various steps in the analysis of patient samples into an integrated workflow – nucleic acid extraction, PCR setup, subsequent real-time PCR and the evaluation of the resul
Grünenthal acquires testosterone treatment NebidoTM from Bayer14.7.2022 08:31:38 CEST | Pressemelding
Grünenthal acquires NebidoTM from Bayer AG for up to € 500 million. The product is expected to add about € 100 million to Grünenthal’s EBITDA in 2023. NebidoTM is the gold standard for the treatment ofmale hypogonadism associated with testosterone deficiency. It is available to patients in over 80 markets worldwide. Grünenthal has invested over € 2 billion in successful M&A transactions over the last years, resulting in a significantly strengthened profitability. Aachen, Germany, 14 July 2022 –Grünenthal, a global science-based, privately-owned pharmaceutical company, today announced an agreement with Bayer AG to acquire NebidoTM, the well-known brand for the treatment of male hypogonadism and its associated brands for up to € 500 million. NebidoTM is the only long-acting injectable treatment for testosterone deficiency. The product is approved and successfully commercialized in over 80 countries. Patent protection exists until March 2024 in the EU and until May 2027 in the US. The bra
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom